Chunghwa Chemical Synthesis & Biotech Co. Mutual Funds

Health Care & Life Sciences » Pharmaceuticals | Chunghwa Chemical Synthesis & Biotech Co. Ltd.

Chunghwa Chemical Synthesis & Biotech Co. Ltd. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

SPDR S&P Emerging Markets ETF

353,000

0.46%

0.02%

09/06/2018

DFA Emerging Markets Core Equity Portfolio

212,000

0.27%

04/30/2018

DFA Emerging Markets Small Cap Series

165,000

0.21%

01/31/2018

John Hancock II - Emerging Markets Fund

16,000

0.02%

04/30/2018

Dimensional Funds ICVC - Emerging Markets Core Equity Fund

14,000

0.02%

12/31/2017

View Profile

Address	No. 1 Dongxing Street New Taipei TP 238 50 Taiwan
Employees	-
Website	http://www.ccsb.com.tw
Updated	07/08/2019
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the manufacture of active pharmaceutical ingredient (API). Its products include pain management for skeletal muscle pain and migraine, immunosuppressant for reducing immune activity after organ transplant, antifungal such as fluconazole,caspofungin and micafungin, oncology that act against cancers, and other APIs for lowering cholesterol and anti diabetic drugs. The company was founded on May 19, 1964 and is headquartered in New Taipei, Taiwan.